Ajay Singh
31Patents
4h-index
52Co-inventors
66Inventor score
Filing activity: Jan 24, 1995 → Feb 16, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5555756A | Method of lubricating steel strip for cold rolling, particularly temper rolling | Chemistry; Metallurgy | 25 | Expired |
| US10874671B2 | Pharmaceutical compositions of nilotinib | Human Necessities | 9 | Active |
| US8115059B1 | Gene expression modulation system for use in plants and method for modulating gene expression in plants | Chemistry; Metallurgy | 8 | Active |
| US8022222B2 | Glucokinase activators | Chemistry; Metallurgy | 4 | Active |
| US8022223B2 | 2-aminopyridine analogs as glucokinase activators | Chemistry; Metallurgy | 2 | Active |
| US8212045B2 | Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus | Chemistry; Metallurgy | 2 | Active |
| US8362037B2 | 2-aminopyridine analogs as glucokinase activators | Chemistry; Metallurgy | 2 | Active |
| US11793809B2 | Pharmaceutical compositions of nilotinib | Human Necessities | 2 | Active |
| US8853409B2 | Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus | Chemistry; Metallurgy | 1 | Active |
| US9125288B2 | Ion-mode plasma containment | Emerging Cross-Sectional Technologies | 1 | Active |
| US9421527B2 | Inorganic nanoparticle deposited catalyst for hydrogenation and manufacturing method of the same, and hydrogenation for biomass derived hydrocarbon compounds | Emerging Cross-Sectional Technologies | 1 | Active |
| US8354540B2 | 2-aminopyridine analogs as glucokinase activators | Chemistry; Metallurgy | 0 | Active |
| US12383491B2 | Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate | Human Necessities | 0 | Active |
| US8580780B2 | 6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist | Chemistry; Metallurgy | 0 | Active |
| US8431713B2 | 2-aminopyridine derivatives as glucokinase activators | Chemistry; Metallurgy | 0 | Active |
| US11642355B2 | Pharmaceutical compositions of testosterone | Human Necessities | 0 | Active |
| US12138271B2 | Pharmaceutical compositions of testosterone | Human Necessities | 0 | Active |
| US8754226B2 | Piperidinyl-substituted lactams as GPR119 modulators | Chemistry; Metallurgy | 0 | Active |
| US11938217B2 | Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate | Human Necessities | 0 | Active |
| US11311554B2 | Pharmaceutical compositions of testosterone | Human Necessities | 0 | Active |
| US11420890B2 | Method of treatment of partially hydrolyzed biosolids | Emerging Cross-Sectional Technologies | 0 | Active |
| US10456354B1 | Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate | Human Necessities | 0 | Active |
| US12403140B2 | Pharmaceutical compositions of nilotinib | Human Necessities | 0 | Active |
| US12151020B2 | Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate | Human Necessities | 0 | Active |
| US11103503B2 | Pharmaceutical compositions of Lurasidone | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.